Correlation Between Shandong Polymer and China Reform

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shandong Polymer and China Reform at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shandong Polymer and China Reform into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shandong Polymer Biochemicals and China Reform Health, you can compare the effects of market volatilities on Shandong Polymer and China Reform and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shandong Polymer with a short position of China Reform. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shandong Polymer and China Reform.

Diversification Opportunities for Shandong Polymer and China Reform

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Shandong and China is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Shandong Polymer Biochemicals and China Reform Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Reform Health and Shandong Polymer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shandong Polymer Biochemicals are associated (or correlated) with China Reform. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Reform Health has no effect on the direction of Shandong Polymer i.e., Shandong Polymer and China Reform go up and down completely randomly.

Pair Corralation between Shandong Polymer and China Reform

Assuming the 90 days trading horizon Shandong Polymer Biochemicals is expected to generate 0.47 times more return on investment than China Reform. However, Shandong Polymer Biochemicals is 2.14 times less risky than China Reform. It trades about 0.06 of its potential returns per unit of risk. China Reform Health is currently generating about -0.03 per unit of risk. If you would invest  474.00  in Shandong Polymer Biochemicals on September 15, 2024 and sell it today you would earn a total of  11.00  from holding Shandong Polymer Biochemicals or generate 2.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Shandong Polymer Biochemicals  vs.  China Reform Health

 Performance 
       Timeline  
Shandong Polymer Bio 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Shandong Polymer Biochemicals are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shandong Polymer sustained solid returns over the last few months and may actually be approaching a breakup point.
China Reform Health 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in China Reform Health are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China Reform sustained solid returns over the last few months and may actually be approaching a breakup point.

Shandong Polymer and China Reform Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shandong Polymer and China Reform

The main advantage of trading using opposite Shandong Polymer and China Reform positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shandong Polymer position performs unexpectedly, China Reform can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Reform will offset losses from the drop in China Reform's long position.
The idea behind Shandong Polymer Biochemicals and China Reform Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world